The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.
T. A. Driscoll
No relevant relationships to disclose
P. L. Martin
No relevant relationships to disclose
J. Moffet
No relevant relationships to disclose
M. Daniel
No relevant relationships to disclose
K. Page
No relevant relationships to disclose
S. Parikh
No relevant relationships to disclose
V. Prasad
No relevant relationships to disclose
P. Szabolcs
No relevant relationships to disclose
J. Kurtzberg
No relevant relationships to disclose